Trials / Completed
CompletedNCT03010475
A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects
A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This trial is conducted in Europe. Tha aim of this trial is to investigate the effect of oral semaglutide on the pharmacokinetics of furosemide and rosuvastatin in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Furosemide | Oral administration A total of three single doses. |
| DRUG | Rosuvastatin | Oral administration. A total of three single doses. |
| DRUG | SNAC | Oral administration. A total of five single doses. |
| DRUG | Semaglutide | Oral administration. Once daily. |
Timeline
- Start date
- 2017-01-05
- Primary completion
- 2017-06-04
- Completion
- 2017-08-09
- First posted
- 2017-01-05
- Last updated
- 2017-12-20
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03010475. Inclusion in this directory is not an endorsement.